← Back to Clinical Trials
Recruiting NCT02194816

NCT02194816 Modifiable Variables in Parkinsonism (MVP)

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT02194816
Status Recruiting
Phase
Sponsor Bastyr University
Condition Parkinson's Disease
Study Type OBSERVATIONAL
Enrollment 2,000 participants
Start Date 2012-09
Primary Completion 2030-12

Eligibility & Interventions

Sex All sexes
Min Age 19 Years
Max Age N/A
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 2,000 participants in total. It began in 2012-09 with a primary completion date of 2030-12.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

We are trying to identify factors associated with improved quality of life and fewer PD symptoms. We are attempting to identify practices, beliefs, and therapies used by individuals who report excellent quality of life, few PD symptoms, and reduced rates of progression. After agreeing to participate, we will ask participants to fill our questionnaires about their experience with PD, their health in general, along with their food intake every six months for five years.

Eligibility Criteria

Inclusion Criteria: * Parkinson's disease (PD) * Parkinsonism * Parkinson-plus syndromes (e.g. Multiple System Atrophy (MSA), Progressive Supranuclear Palsy (PSP), Corticobasal degeneration (CBGD), Dementia with Lewy bodies) * Must have online access, an email address, basic computer literacy * Must be willing to complete online surveys every 6 months for 5 years Exclusion Criteria: * Inability to read/write English * Inability or unwillingness to complete surveys every six (6) months (\~90 min)

Contact & Investigator

Central Contact

Research Assistant

✉ neuroresearch@bastyr.edu

📞 425-602-3306

Principal Investigator

Laurie K Mischley, ND, PhD, MPH

PRINCIPAL INVESTIGATOR

Bastyr University

Frequently Asked Questions

Who can join the NCT02194816 clinical trial?

This trial is open to participants of all sexes, aged 19 Years or older, studying Parkinson's Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT02194816 currently recruiting?

Yes, NCT02194816 is actively recruiting participants. Contact the research team at neuroresearch@bastyr.edu for enrollment information.

Where is the NCT02194816 trial being conducted?

This trial is being conducted at Kenmore, United States.

Who is sponsoring the NCT02194816 clinical trial?

NCT02194816 is sponsored by Bastyr University. The principal investigator is Laurie K Mischley, ND, PhD, MPH at Bastyr University. The trial plans to enroll 2,000 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology